Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection
- PMID: 27693539
- DOI: 10.1016/j.jhep.2016.09.013
Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection
Abstract
Background & aims: Cirrhosis related to chronic hepatitis B (CHB) is a major risk factor for hepatocellular carcinoma (HCC). The extent to which HCC occurs in U.S. in the absence of cirrhosis in CHB remains unclear.
Methods: We identified CHB patients who were diagnosed with HCC in the national Veterans Administration (VA) between 2001 and 2013. We defined presence and absence of cirrhosis at the time of HCC diagnosis using explicit histological, radiological, endoscopic, and laboratory criteria. We used multivariable regression analysis to identify demographic and clinical characteristics associated with CHB-related HCC in the absence of cirrhosis. We also examined liver transplant-free survival in CHB-HCC patients with and without cirrhosis.
Results: Among 8539 CHB patients, 317 developed HCC of whom 30 (9.5%) did not have any evidence of cirrhosis at the time of HCC diagnosis. Compared to HCC patients with cirrhosis, HCC patients without cirrhosis were more likely to be non-white (African American, OR=6.78; 95% CI 2.05-22.4; Asian, OR 11.6, 95% CI 2.63-50.8), have a family history of HCC (OR 32.9, 95% CI 3.76-288), and hypertension (OR 3.15, 95% CI 1.02-9.75). There was no significant difference in the transplant-free survival between CHB-HCC patients with and without cirrhosis (hazard ratio 0.68, 95% CI 0.43-1.09).
Conclusions: Fewer than 10% of U.S. based CHB-related HCC patients did not have cirrhosis. Race and family history of HCC were the main risk factors for HCC in the absence of cirrhosis in CHB. These factors may help guide the decision to initiate HCC surveillance in CHB patients without cirrhosis.
Lay summary: Patients with chronic hepatitis B who are African American, or Asian, older than 40years of age with family members with liver cancer or high blood pressure are at a higher risk of developing liver cancer in the absence of cirrhosis. These patients should be included in the screening program for liver cancer.
Keywords: Chronic hepatitis B; Cirrhosis; Epidemiology; Hepatocellular carcinoma; Liver cirrhosis; Liver transplantation; Risk factors.
Copyright © 2016 European Association for the Study of the Liver. All rights reserved.
Comment in
-
Inappropriate use of FIB-4 index for cirrhosis detection in hepatocellular carcinoma patients.J Hepatol. 2017 Oct;67(4):883-884. doi: 10.1016/j.jhep.2017.04.029. Epub 2017 Jun 19. J Hepatol. 2017. PMID: 28636897 No abstract available.
-
Reply to: "Hepatocellular carcinoma (HCC) in the absence of cirrhosis in patients with chronic hepatitis B virus infection".J Hepatol. 2017 Oct;67(4):886-887. doi: 10.1016/j.jhep.2017.06.005. Epub 2017 Jun 19. J Hepatol. 2017. PMID: 28636898 No abstract available.
-
Reply to: "Inappropriate use of FIB-4 index for cirrhosis detection in hepatocellular carcinoma patients".J Hepatol. 2017 Oct;67(4):884-885. doi: 10.1016/j.jhep.2017.06.004. Epub 2017 Jun 19. J Hepatol. 2017. PMID: 28636899 No abstract available.
-
Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection.J Hepatol. 2017 Oct;67(4):885-886. doi: 10.1016/j.jhep.2017.05.030. Epub 2017 Jun 22. J Hepatol. 2017. PMID: 28647566 No abstract available.
Similar articles
-
Screening is associated with a lower risk of hepatocellular carcinoma-related mortality in patients with chronic hepatitis B.J Hepatol. 2021 Apr;74(4):850-859. doi: 10.1016/j.jhep.2020.11.023. Epub 2020 Nov 24. J Hepatol. 2021. PMID: 33245934 Free PMC article.
-
The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.Gut. 2016 Sep;65(9):1514-21. doi: 10.1136/gutjnl-2015-310686. Epub 2015 Dec 7. Gut. 2016. PMID: 26642861
-
Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis.J Med Assoc Thai. 2015 Apr;98(4):334-42. J Med Assoc Thai. 2015. PMID: 25958707
-
High Prevalence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Thailand.Asian Pac J Cancer Prev. 2016;17(6):2857-60. Asian Pac J Cancer Prev. 2016. PMID: 27356702
-
Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients.World J Gastroenterol. 2016 Oct 7;22(37):8314-8321. doi: 10.3748/wjg.v22.i37.8314. World J Gastroenterol. 2016. PMID: 27729738 Free PMC article. Review.
Cited by
-
Mesenchymal stem cells-based therapy in liver diseases.Mol Biomed. 2022 Jul 27;3(1):23. doi: 10.1186/s43556-022-00088-x. Mol Biomed. 2022. PMID: 35895169 Free PMC article. Review.
-
Hepatitis B Virus-Associated Hepatocellular Carcinoma.Viruses. 2022 May 7;14(5):986. doi: 10.3390/v14050986. Viruses. 2022. PMID: 35632728 Free PMC article. Review.
-
Hepatitis B Virus-Associated Hepatocellular Carcinoma and Chronic Stress.Int J Mol Sci. 2022 Apr 1;23(7):3917. doi: 10.3390/ijms23073917. Int J Mol Sci. 2022. PMID: 35409275 Free PMC article. Review.
-
Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg).J Clin Med. 2022 Feb 21;11(4):1126. doi: 10.3390/jcm11041126. J Clin Med. 2022. PMID: 35207397 Free PMC article. Review.
-
[Hepatitis B and C: mechanisms of virus-induced liver pathogenesis and tumorigenesis].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 Feb;65(2):228-237. doi: 10.1007/s00103-021-03482-y. Epub 2022 Jan 11. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022. PMID: 35015106 Free PMC article. Review. German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
